黄芪甲甙治疗胸壁放射性皮炎的疗效

Astragaloside in treatment of radioactive dermatitis of chest wall in breast cancer patients

摘要:

目的  观察黄芪甲甙治疗乳腺癌并发胸壁放射性皮炎的临床疗效。方法  60例行胸壁放疗并发胸壁放射性皮炎患者，随机分为治疗组和对照组，治疗组采用黄芪甲甙均匀喷涂创面，对照组采用3%硼酸水或1%碘伏等常规治疗。结果  治疗组皮肤创面愈合时间明显短于对照组，且治疗组有效率也高于对照组，差异有统计学意义（P =0.012）。结论  黄芪甲甙能有效治疗乳腺癌患者放疗后并发的胸壁放射性皮炎，创面愈合期较短。

Abstract:

Objective To observe the clinical effect of Astragaloside on radioactive dermatitis of chest wall in breast cancer patients. Methods Sixty cases of breast cancer, who suffered from radiation dermatitis after chest wall radiotherapy, were divided into treatment group and control group． The wounds of the patients in the treatment group were plastered with Astragaloside. As controls, the wounds of the patients in the control group were plastered with 3% boric acid or 1% iodophor. Results The wound healing time of the control group was significantly longer than that of the treatment group, and the total effective rate of the treatment group was significantly higher than that of the control group (P = 0.012). Conclusions Astragaloside can effectively cure the radioactive dermatitis in breast cancer patients and shorten the wound healing time.